Chronic Obstructive Pulmonary Disease References

Last updated: 17 March 2026
Reviewed by
  1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995 Nov;152(5)(Pt 2):S77-S121. PMID: 7582322
  2. The Asia Pacific COPD Roundtable Group. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology. 2005 Jan;10(1):009-17. PMID: 15691232
  3. Ambrosino N, Vagheggini G. Non-invasive ventilation in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2007 Dec;2(4):471-476. PMID: 18268921
  4. Blanchard AR. Treatment of COPD exacerbations: pharmacologic options and modification of risk factors. Postgrad Med. 2002 Jun;111(6):65-75. PMID: 12082921
  5. Decramer M, Celli B, Kesten S, et al; UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009 Oct;374(9696):1171-1178. PMID: 19716598
  6. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health study. Chest. 2009 Dec;136(6):1456-1465. doi: 10.1378/chest.08-3016. PMID: 19581353
  7. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [full version of NICE guideline No.12]. Thorax. 2004 Feb;59(Suppl 1):001-232. PMID: 15041752
  8. Doherty DE. Early detection and management of COPD: what you can do to reduce the impact of this disabling disease. Postgrad Med. 2002 Jun;111(6):41-4, 49-50, 53 passim. PMID: 12082920
  9. Gross N, Levin D. Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of disease. Am J Med. 2008 Jul;121(7)(Suppl):S13-S24. PMID: 18558103
  10. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J. 2007 Sep;14(Suppl B):5B-32B. doi: 10.1155/2007/830570. PMID: 17885691
  11. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J. 2008 Jan;15(Suppl Suppl A):1A-8A. doi: 10.1155/2008/641965. PMID: 18292855
  12. Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008 Oct;359(15):1543-1554. PMID: 18836213
  13. Qaseem A, Snow V, Shekelle P, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007 Nov;147(9):633-638. PMID: 17975186
  14. Rennard SI. Overview of causes of COPD. New understanding of pathogenesis and mechanisms can guide future therapy. Postgrad Med. 2002 Jun;111(6):28-38. PMID: 12082919
  15. Snow V, Lascher S, Mottur-Pilson C; Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians and the American College of Physicians-American Society of Internal Medicine. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001 Apr;134(7):595-599. PMID: 11281744
  16. Yassin HM, Dever LL. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections. Expert Opin Investig Drugs. 2001 Feb;10(2):353-367. PMID: 11178347
  17. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. http://guidance.nice.org.uk/. 2010.
  18. Ministry of Health (MOH) Singapore. Clinical practice guidelines: chronic obstructive pulmonary disease. MOH Singapore. http://www.moh.gov.sg. 2006.
  19. National Institute for Health and Care Excellence (NICE). Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. NICE. https://www.nice.org.uk. 2004.
  20. Alberta Medical Association. Guideline for the management of acute exacerbations of chronic bronchitis (AECB)/acute or chronic COPD. Alberta Medical Association. http://www.albertadoctors.org/. May 2000. Accessed 05 Aug 2002.
  21. Institute for Clinical Systems Improvement (ICSI). Health care guideline: chronic obstructive pulmonary disease. http://www.icsi.org. 2004
  22. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug;155(3):179-191. doi: 10.7326/0003-4819-155-3-201108020-00008. PMID: 21810710
  23. American Thoracic Society. COPD assessment test (CAT). American Thoracic Society website. http://www.thoracic.org/. 2014.
  24. Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 Mar;49(3). doi: 10.1183/13993003.00791-2016. Accessed 5 Nov 2018. PMID: 28298398
  25. Ferguson GT, Make B. Management of stable chronic obstructive pulmonary disease. UpToDate. https://www.uptodate.com. Jan 2019. Accessed 21 Feb 2019.
  26. Agency for Care Effectiveness (ACE), Ministry of Health Singapore. Appropriate care guide: diagnosing chronic obstructive pulmonary disease: A systematic approach. ACE. http://www.ace-hta.gov.sg/. Nov 2018. Accessed 14 May 2019.
  27. Agency for Care Effectiveness (ACE), Ministry of Health Singapore. Appropriate care guide: managing stable chronic obstructive pulmonary disease: Focusing on inhalers. ACE. http://www.ace-hta.gov.sg/. Sep 2018. Accessed 14 May 2019.
  28. Agency for Care Effectiveness (ACE), Ministry of Health Singapore. Long-acting muscarinic antagonist (LAMA) monotherapy and combination therapy with long-acting beta2 agonists (LAMA/LABA) for the treatment of chronic obstructive pulmonary disease: Technology Guidance from the MOH Drug Advisory Committee. ACE. http://www.ace-hta.gov.sg/. Jul 2018. Accessed 14 May 2019.
  29. Guidelines and Protocols Advisory Committee, British Columbia Medical Association (BCMA). Chronic obstructive pulmonary disease (COPD): diagnosis and management. British Columbia Ministry of Health. https://www2.gov.bc.ca/. Feb 2017. Accessed 21 Feb 2019.
  30. Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J. 2017 Nov;50(5). doi: 10.1183/13993003.00610-2017. Accessed 21 Feb 2019. PMID: 29191952
  31. National Institute for Health and Care Excellence (NICE). Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing. NICE. https://www.nice.org.uk/. Dec 2018. Accessed 21 Feb 2019.
  32. National Institute for Health and Clinical Excellence (NICE). Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE. https://www.nice.org.uk. Dec 2018. Accessed 21 Feb 2019.
  33. Stoller JK. Management of exacerbations of chronic obstructive pulmonary disease. UpToDate. http://www.uptodate.com/. Jan 2019. Accessed 21 Feb 2019.
  34. Wedzicha JA, Calverley PMA, Albert RK, et al. Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 Sep;50(3). doi: 10.1183/13993003.02265-2016. Accessed 21 Feb 2019. PMID: 28889106
  35. Celli BR. Pulmonary rehabilitation. UpToDate. https://www.uptodate.com. 12 Jul 2018. Accessed 14 Nov 2019.
  36. Ferguson GT, Make B. Stable COPD: Follow-up pharmacologic management. UpToDate. https://www.uptodate.com. 31 Oct 2019. Accessed 11 Nov 2019.
  37. Bourbeau J, Bhutani M, Hernandez P, et al. Canadian Thoracic Society clinical practice guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2019 Oct;3(4):210-232. doi: 10.1080/24745332.2019.1668652. Accessed 17 Mar 2021
  38. Ergan B, Oczkowski S, Rochwerg B, et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Reps J. 2019 Sep;54(3):1901003. doi: 10.1183/13993003.01003-2019. Accessed 17 Mar 2021. PMID: 31467119
  39. Ferguson GT, Make B. Management of refractory chronic obstructive pulmonary disease. UpToDate. https://www.uptodate.com. 11 Jun 2020. Accessed 17 Mar 2021.
  40. Ferguson GT, Make B. Stable COPD: initial pharmacologic management. UpToDate. https://www.uptodate.com. 17 Dec 2021. Accessed 17 Mar 2021.
  41. Macrea M, Oczkowski S, Rochwerg B, et al. Long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020 Aug;202(4):e74-e87. doi: 10.1164/rccm.202006-2382ST. Accessed 17 Mar 2021. PMID: 32795139
  42. Stoller JK. COPD exacerbations: management. UpToDate. https://www.uptodate.com. 30 Nov 2020. Accessed 17 Mar 2021.
  43. Limpoco AG, Palma-Mendoza NRN, Sta. Ana J. Effectiveness of health education interventions directed to patient, family, community on chronic obstructive pulmonary disease in family and community practice: a meta-analysis. The Filipino Family Physician. 2021;59(1):2-18.
  44. Philippine College of Chest Physicians (PCCP) Council on Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Rehabilitation, 2018-2021. 2021 Summary of consensus statements on the diagnosis and management of COPD in the Philippines. PCCP. https://philchest.org/. 2021. Accessed 16 Jun 2022.
  45. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2023 report. GOLD. http://www.goldcopd.org/. 2023.
  46. Stoller JK. COPD exacerbations: management. UpToDate. https://www.uptodate.com/. 30 Dec 2022.
  47. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report. GOLD. https://www.goldcopd.org/. 2024. Accessed 22 Apr 2024.
  48. Kobayashi M, Leidner AJ, Gierke R, et al. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2025 Jan;74(1):1-8. doi: 10.15585/mmwr.mm7401a1. Accessed 17 Mar 2025. PMID: 39773952
  49. Centers for Disease Control & Prevention (CDC). RSV vaccine guidance for older adults. CDC. https://www.cdc.gov/. 30 Aug 2024. Accessed 17 Jun 2025.
  50. Lee PI, Huang YC, Liu CC, et al. Recommendation for the use of respiratory syncytial virus vaccines. J Microbiol Immunol Infect. 2025 Feb;58(1):1-6. doi: 10.1016/j.jmii.2024.12.010. Accessed 18 Jun 2025. PMID: 39794196
  51. Bhatt SP, Rabe KF, Hanania NA, et al; BOREAS Investigators. Dupilumab for COPD with type 2 Inflammation indicated by eosinophil counts. N Engl J Med. 2023 Jul;389(3):205-214. doi: 10.1056/NEJMoa2303951. PMID: 37272521
  52. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2026 report. GOLD. http://www.goldcopd.org/. 2026.